Challenges of biomarkers in drug discovery and development.
about
Bridging academic science and clinical research in the search for novel targeted anti-cancer agentsMurine models of inflammatory bowel disease (IBD): challenges of modeling human diseaseRegulatory perspective on remaining challenges for utilization of pharmacogenomics-guided drug developments.Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?Optimizing drug development in oncology by clinical trial simulation: Why and how?Robust and tissue-independent gender-specific transcript biomarkers.
P2860
Challenges of biomarkers in drug discovery and development.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Challenges of biomarkers in drug discovery and development.
@en
Challenges of biomarkers in drug discovery and development.
@nl
type
label
Challenges of biomarkers in drug discovery and development.
@en
Challenges of biomarkers in drug discovery and development.
@nl
prefLabel
Challenges of biomarkers in drug discovery and development.
@en
Challenges of biomarkers in drug discovery and development.
@nl
P2860
P1476
Challenges of biomarkers in drug discovery and development.
@en
P2093
Federico Goodsaid
P2860
P304
P356
10.1517/17460441.2012.679615
P407
P577
2012-04-04T00:00:00Z